LOS ANGELES, CA, USA I July 30, 2025 I Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced ...
GENEVA, Switzerland I November 3, 2016 I Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, announced today it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results